Jacob Hooker
About Jacob Hooker
Jacob Hooker serves as the Editor in Chief of ACS Chemical Neuroscience and has a strong background in chemistry and neuroscience. He has held various academic and advisory positions, including roles at Harvard Medical School and Massachusetts General Hospital, and co-founded multiple therapeutic companies.
Work at American Chemical Society
Jacob Hooker currently serves as the Editor-in-Chief of ACS Chemical Neuroscience, a position he has held since 2020. He previously worked as an Associate Editor for the same journal from 2013 to 2020. His role involves overseeing the publication process and ensuring the quality of research disseminated in the field of chemical neuroscience.
Education and Expertise
Jacob Hooker earned his Ph.D. in Chemistry from the University of California, Berkeley, where he studied from 2002 to 2007. He also holds a Bachelor of Science in Chemistry from North Carolina State University, completed from 1998 to 2002. His educational background supports his focus on building large-scale programs for translational impact in neuroscience.
Background
Jacob Hooker has a diverse professional background in academia and industry. He has been associated with prestigious institutions such as Harvard Medical School, where he served as an Associate Professor of Radiology from 2014 to 2020, and currently holds a position as a Professor of Radiology since 2020. He has also been involved with Massachusetts General Hospital in various roles since 2009.
Achievements
Jacob Hooker co-founded Eikonizo Therapeutics in 2017 and Sensorium Therapeutics in 2021. He has been a Scientific Advisor for several organizations, including Psy Therapeutics, Inc., Delix Therapeutics, and Rocket Science Health. His work includes advising on strategies related to novel therapeutics and digital products in healthcare, as well as taking projects from ideation through clinical trials.
Current Roles and Responsibilities
Jacob Hooker currently holds multiple positions, including MIT linQ Catalyst Faculty at the Massachusetts Institute of Technology since 2010, Director of Radiochemistry at the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital since 2009, and Scientific Director at the Lurie Center for Autism since 2021. He also serves as a Strategic Advisor at Human Health since 2022.